Treatment outcomes and key factors contributing to unfavourable outcomes among isoniazid-resistant pulmonary tuberculosis patients in Shanghai, China
Objective: Given that more than 1 million people annually develop isoniazid-resistant tuberculosis (Hr-TB), the issue of Hr-TB may go unnoticed. However, limited studies have focused on the clinical treatment of Hr-TB in China, particularly regarding treatment outcomes and influencing factors. This...
Saved in:
| Main Authors: | Wenjing Xiao, Jing Chen, Lixin Rao, Xiao Xiao, Xubin Zheng, Zheyuan Wu, Xin Shen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Journal of Global Antimicrobial Resistance |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2213716525000372 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Relapse of Pulmonary Tuberculosis in Patients with Resistance to Isoniazid
by: I. A. Burmistrova, et al.
Published: (2023-07-01) -
Efficacy of Various Approaches to Treatment of Patients with Isoniazid Resistant Pulmonary Tuberculosis
by: I. A. Burmistrova, et al.
Published: (2023-12-01) -
The efficacy of the combination drug of hydroxymethylquinoxalinedioxide + isoniazid lyophilisate in the treatment of bronchial tuberculosis
by: A. A. Stаrshinovа
Published: (2019-05-01) -
Is a 6-month Treatment for Isoniazid-resistant Tuberculosis Effective?
by: A. I. Kulizhskaya, et al.
Published: (2022-03-01) -
Isoniazid-induced Choroidal Effusion: A Rare Presentation
by: Amit S. Nene, et al.
Published: (2024-04-01)